ALISON BRATMAN: Open Payments
NPI 1083224265 · HACKETTSTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,575 in 86 payments from 15 companies in 2025. Trend: 2023 $923 · 2024 $1,465 · 2025 $1,575
Food & beverage: $1,410Education: $165
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $381 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $184 |
| GENZYME CORPORATION | 11 | $161 |
| Regeneron Healthcare Solutions, Inc. | 4 | $153 |
| Janssen Biotech, Inc. | 5 | $145 |
| E.R. Squibb & Sons, L.L.C. | 6 | $95 |
| PFIZER INC. | 4 | $87 |
| Amgen Inc. | 4 | $67 |
| Arcutis Biotherapeutics, Inc. | 3 | $49 |
| Almirall LLC | 2 | $45 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, BOTOX, Sotyktu, Winlevi, ILUMYA, OTEZLA.
Industry payments across NJ — which companies pay providers there.
